Home › All Companies › CAH

CARDINAL HEALTH INC (CAH)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-04-30

Key Insights

  • Cardinal Health announced Q3 FY2026 results (quarter ended March 31, 2026) on April 30, 2026, with detailed financial performance metrics disclosed in the accompanying news release.
  • Management will host a webcast at 8:30 a.m. ET on April 30, 2026 featuring the CEO and CFO discussing quarterly results and providing fiscal year 2026 (ending June 30) outlook, indicating active investor communication.
  • The filing is a routine earnings announcement with no material events, executive changes, acquisitions, or strategic developments disclosed beyond standard quarterly results reporting.
Sentiment: Neutral Significance: 3/10
View Original Filing →
Quarterly Report Filed: 2026-04-30

Key Insights

  • Filing contains extensive segment reporting across Pharmaceutical and Specialty Solutions, GMPD, and other segments with multiple acquisitions tracked including Solaris Health, GIA, ADS, ION, and Urology America indicating active M&A activity and portfolio diversification.
  • Complex organizational structure with variable interest entities and noncontrolling interests suggests Cardinal Health is managing multiple joint ventures and consolidated entities, which could impact transparency and require careful analysis of equity attribution.
  • Presence of multiple intangible asset categories (customer contracts, trademarks, patents, developed technology rights, noncompete agreements) across acquisitions indicates substantial goodwill that may require impairment testing if operational performance deteriorates.
Sentiment: Neutral Significance: 5/10
View Original Filing →
Insider Trading Filed: 2026-04-17

Key Insights

  • Patricia Hemingway Hall, a director of Cardinal Health Inc. (CAH), acquired 381 additional restricted stock units (RSUs) on April 15, 2026, at a price of $207.83 per share, indicating her increased commitment to the company.
  • The RSU grant was made in connection with Hemingway Hall's elevation to the role of Chair of the Board, effective March 20, 2026, suggesting her expanded leadership role within the organization.
  • Insider buying, particularly by the Chair of the Board, can be a positive signal to investors about management's confidence in the company's future prospects.
Sentiment: Positive Significance: 7/10
View Original Filing →
Current Report Filed: 2026-03-23

Key Insights

  • Cardinal Health has announced the retirement of Gregory B. Kenny from the Board of Directors, effective March 20, 2026. The Board has appointed Patricia A. Hemingway Hall as the new Board Chair.
  • The company has reaffirmed its fiscal 2026 outlook and plans to release its third quarter earnings on April 30, 2026.
  • The filing does not indicate any disagreements between the company and Mr. Kenny, suggesting a smooth transition in the leadership of the Board.
Sentiment: Positive Significance: 6/10
View Original Filing →
Current Report Filed: 2026-03-05

Key Insights

  • Cardinal Health, Inc. announced the upcoming retirement of Mary Scherer, Senior Vice President and Chief Accounting Officer, in February 2027. The company will initiate a search process to identify her successor.
  • The transition plan appears to be well-managed, with Ms. Scherer remaining in her role until her successor is identified and onboarded, ensuring a smooth transition.
  • This leadership change is a routine event for the company and is not expected to have a significant impact on its operations or financial performance.
Sentiment: Neutral Significance: 3/10
View Original Filing →
Insider Trading Filed: 2026-03-03

Key Insights

  • Insider Michelle D. Greene, the Chief Information Officer, sold 2,746 shares of Cardinal Health Inc. (CAH) on February 27, 2026 at an average price of $228.51.
  • The total sale amount was approximately $627,000, reducing Greene's direct shareholdings from 14,876 shares to 12,230 shares.
  • Insider selling can sometimes signal a lack of confidence in the company's future prospects, though a single transaction does not necessarily indicate a broader trend.
Sentiment: Neutral Significance: 4/10
View Original Filing →
Insider Trading Filed: 2026-02-18

Key Insights

  • Insider Aaron E. Alt, Chief Financial Officer of Cardinal Health, sold 2,328 shares on 02/18/2026, indicating potential bearish sentiment.
  • Alt also withheld 1,914 shares on 02/15/2026 to cover tax obligations, which could suggest a need for liquidity.
  • The insider transactions totaled approximately $517,000, representing a notable portion of Alt's beneficial ownership of 26,408 shares.
Sentiment: Negative Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-02-10

Key Insights

  • Patricia Hemingway Hall, a director of Cardinal Health Inc. (CAH), sold 4,000 common shares on February 6, 2026 at an average price of $229.72 per share.
  • The sale reduced Hall's direct beneficial ownership in CAH to 28,264 shares, continuing a trend of insider selling at the company.
  • Insider transactions can provide signals about management's outlook on the company's prospects, and this sale may warrant further investigation by investors.
Sentiment: Neutral Significance: 5/10
View Original Filing →
Current Report Filed: 2026-02-05

Key Insights

  • Cardinal Health reported strong Q2 2026 results, with revenue and earnings exceeding expectations.
  • The company provided an optimistic outlook for the full fiscal year 2026, indicating continued growth and margin improvement.
  • The results suggest Cardinal Health is effectively navigating industry challenges and positioning itself for future success.
Sentiment: Positive Significance: 7/10
View Original Filing →
Quarterly Report Filed: 2026-02-05

Key Insights

  • The company reported a decline in revenue and profitability compared to the prior year period, indicating potential operational challenges.
  • Cardinal Health faced legal issues related to unspecified lawsuits, which could expose the company to financial and reputational risks.
  • The company's segment performance was mixed, with the Pharmaceutical and Specialty Solutions segment showing signs of weakness while the GMPD segment performed relatively better.
Sentiment: Negative Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-01-20

Key Insights

  • Valerie Christine Pitteroff, the Chief Human Resources Officer of Cardinal Health Inc. (CAH), acquired 3,982 common shares of the company through a restricted share unit (RSU) grant on January 15, 2026.
  • The grant of RSUs vests in three equal annual installments starting on August 15, 2027, indicating the company's commitment to retaining and incentivizing its key executive talent.
  • Pitteroff also holds an additional 463 common shares through the company's 401(k) plan, demonstrating her continued confidence and alignment with Cardinal Health's long-term performance.
Sentiment: Positive Significance: 5/10
View Original Filing →
Current Report Filed: 2026-01-13

Key Insights

  • Cardinal Health, Inc. has provided an update to its previously issued fiscal year 2026 non-GAAP earnings per share outlook, which could signal changes in the company's financial performance.
  • The company is scheduled to appear at the 44th Annual J.P. Morgan Healthcare Conference, which could provide investors with insights into the company's strategic direction and growth plans.
  • The filing indicates that Cardinal Health, Inc. is not an emerging growth company, suggesting it is a more established player in the healthcare industry.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.